BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 36174477)

  • 21. Minimizing Glycemic Fluctuations in Patients with Type 2 Diabetes: Approaches and Importance.
    Dandona P
    Diabetes Technol Ther; 2017 Sep; 19(9):498-506. PubMed ID: 28771387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of structured diabetes education on glycemic control during Ramadan fasting in diabetic patients in Beni Suef, Egypt.
    Nassar M; Ahmed TM; AbdAllah NH; El Sayed El Hadidy K; Sheir RE
    Diabetes Metab Syndr; 2021; 15(5):102249. PubMed ID: 34418633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
    Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
    Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes.
    Vianna AGD; Lacerda CS; Pechmann LM; Polesel MG; Marino EC; Faria-Neto JR
    Diabetes Res Clin Pract; 2018 May; 139():357-365. PubMed ID: 29596951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose.
    Kasthuri S; Poongothai S; Anjana RM; Selvakumar J; Muthukumar S; Kayalvizhi S; Tariq S; Honey E; Gupta PK; Venkatesan U; Mohan V
    Diabetes Technol Ther; 2021 Mar; 23(3):213-220. PubMed ID: 32916063
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluating the impact of Ramadan fasting on ambulatory glucose profile among patients with type 1 diabetes using Flash Glucose Monitoring System: A comparative study.
    Al Hayek AA; Robert AA; Al Dawish MA
    Diabetes Metab Syndr; 2022 Apr; 16(4):102472. PubMed ID: 35366597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Real-World Prospective Study of the Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting.
    Al-Sofiani ME; Alharthi S; Albunyan S; Alzaman N; Klonoff DC; Alguwaihes A
    Diabetes Care; 2024 Apr; 47(4):683-691. PubMed ID: 38290134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy.
    Grace T; Salyer J
    Diabetes Technol Ther; 2022 Jan; 24(1):26-31. PubMed ID: 34524013
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
    Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility Study.
    Oser TK; Cucuzzella M; Stasinopoulos M; Moncrief M; McCall A; Cox DJ
    JMIR Diabetes; 2022 Feb; 7(1):e34465. PubMed ID: 35050857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.
    Klarskov CK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL
    Trials; 2020 Nov; 21(1):968. PubMed ID: 33239100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between daily and visit-to-visit glycemic variability in patients with type 2 diabetes.
    Tsuchiya T; Saisho Y; Murakami R; Watanabe Y; Inaishi J; Itoh H
    Endocr J; 2020 Aug; 67(8):877-881. PubMed ID: 32389920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring.
    Juel CTB; Dejgaard TF; Hansen CP; Storkholm JH; Vilsbøll T; Lund A; Knop FK
    J Clin Endocrinol Metab; 2021 Jan; 106(1):168-173. PubMed ID: 33053154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations Between Glycemic Parameters Obtained from Continuous Glucose Monitoring and Hemoglobin A1c and Glycoalbumin Levels in Type 2 Diabetes Mellitus.
    Sonoda S; Okada Y; Torimoto K; Sugai K; Uemura F; Tanaka K; Hajime M; Mori H; Tanaka Y
    J UOEH; 2020; 42(4):299-306. PubMed ID: 33268606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study.
    Lu J; Ma X; Zhang L; Mo Y; Lu W; Zhu W; Bao Y; Jia W; Zhou J
    Diabetes Res Clin Pract; 2020 Mar; 161():108032. PubMed ID: 32006646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial.
    Majithia AR; Kusiak CM; Armento Lee A; Colangelo FR; Romanelli RJ; Robertson S; Miller DP; Erani DM; Layne JE; Dixon RF; Zisser H
    J Med Internet Res; 2020 Aug; 22(8):e21778. PubMed ID: 32856597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study).
    Bae JC; Kwak SH; Kim HJ; Kim SY; Hwang YC; Suh S; Hyun BJ; Cha JE; Won JC; Kim JH
    Diabetes Metab J; 2022 Jan; 46(1):81-92. PubMed ID: 34130378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.